Current share price for PKY : $0.056 0.003 (4.31%)+
Pathkey.AI Ltd (PKY, formerly Opyl Limited), an ASX-listed company, is an AI company dedicated to using data and technology to transform the landscape of clinical trials and medical research.
| ASX Code | PKY |
| Website | http://www.pathkey.ai |
| Industry/Sector | Application Software |
| Market Cap ($M) | 33 |
| PKY Share Price | $0.056 |
| Day High | $0.060 |
| Day Low | $0.055 |
| Last Close | $0.058 |
| PKY Share Price Movement | $0.00 ( 4.31% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Pathkey.AI Ltd (PKY) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$1.45 | -$0.80 | -57.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$3.12 | -$1.80 | -15.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$1.73 | -$2.20 | -43.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Life360 Inc (360) | $3,940M | -32.1265 | -0.1034 | 0.3640 | 21.5964 | 24.0876 | 17.6599 | 0.00% | 0.00% | 0.00% |
| Pathkey.AI Ltd (PKY) | $33M | -0.5792 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Technology One Limited (TNE) | $10,247M | 0.1582 | 0.1924 | 0.2094 | 75.0060 | 62.9019 | 52.0106 | 1.17% | 1.10% | 1.33% |
| Wisetech Global Limited (WTC) | $12,604M | 0.3104 | -0.1328 | 0.5623 | 35.2775 | 40.6813 | 26.0399 | 0.59% | 0.53% | 0.71% |
| Xero Limited (XRO) | $12,539M | 0.0000 | 0.0000 | 0.8378 | 0.0000 | 67.5489 | 36.7555 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -52.70 | 0.00 |
| Market | 0.29 | 13.20 | 1.18 | 0.70 |
| Sector | 1.50 | 25.10 | 2.69 | 0.82 |
| Name | Position | Start Date |
|---|---|---|
| Mr Damon Rasheed | Executive Director | 1 Feb 2019 |
| Ms Shannon Jayne Robinson | Non-Executive Chairman, Non-Executive Director | 28 Nov 2025 |
| Mr Paul Clement Niardone | Non-Executive Director | 21 Oct 2025 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 4 Feb 2026 | NIARDONE, Paul | Buy | Indirect Shares | 2,000,000 | $0.012 | $24,000.000 |
| 21 Oct 2025 | JAIN, Saurabh | Sell | Indirect Shares | 5,546,712 | $0.020 | $113,543.730 |
| 28 Mar 2025 | GUOGA, Antanas (Tony) | Buy | Direct Shares | 3,059 | $85.650 | $262,003.350 |
See all changes in directors' interest & trades for Pathkey.AI Ltd (PKY) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Andrew Farnsworth | Chief Executive Officer |
| Jonathan Hart | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Pathkey.AI Ltd (PKY). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 21,658,802 (17.70%) | Antanas Guoga |
| 14,783,240 (12.08%) | Irwin Biotech Nominees Pty Ltd |
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 29 January 2027 | Report (Quarterly) |
| 21 September 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.